In the latest article from SIDP, here is a look at the use of various intravenous (IV) antimicrobial therapies to address infections in these patients.
M. Gabriela Cabanilla, PharmD, PhC
Advertisement
M. Gabriela Cabanilla, PharmD, PhC is an assistant professor at the University of New Mexico College of Pharmacy and an inpatient infectious diseases pharmacist clinician at the University of New Mexico Hospital in Albuquerque, NM. Cabanilla's clinical interests include immunocompromised infectious diseases and optimizing antimicrobial dosing in the critically ill, particularly in ECMO.
Articles by M. Gabriela Cabanilla, PharmD, PhC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Approves IV Antbiotic, Contepo, for Complicated Urinary Tract Infections
2
Listeria Outbreak Update: 27 Illnesses and 6 Deaths Linked to Packaged Meals
3
Clesrovimab Lowers RSV Hospitalizations and Illness in Healthy Infants
4
FDA Clears Immuron’s IMM-529 For Clinical Testing in C difficile; Phase 2 Set to Begin in Australia
5
